ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2007;84:2066-2069. doi:10.1016/j.athoracsur.2007.07.021
© 2007 The Society of Thoracic Surgeons

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard D. Mainwaring
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mainwaring, R. D.
Right arrow Articles by Fallah, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mainwaring, R. D.
Right arrow Articles by Fallah, H.
Related Collections
Right arrow Congenital - acyanotic


Original Articles: Cardiovascular

Brain Natriuretic Peptide Levels Before and After Ventricular Septal Defect Repair

Richard D. Mainwaring, MDa,*, Carol Parise, PhDb, Stanley B. Wright, MDa, Andrew L. Juris, MDa, Robert A. Achtel, MDa, Hessam Fallah, MDa

a Sutter Medical Center, Sacramento, California
b Sutter Institute for Medical Research (SIMR), Sacramento, California

Accepted for publication July 9, 2007.

* Address correspondence to Dr Mainwaring, 5301 F St, Ste 213, Sacramento, CA 95819 (Email: mainwar{at}sutterhealth.org).


    Abstract
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Background: Brain natriuretic peptide is a relatively recently discovered circulating mediator that has been correlated with the degree of heart failure in adults. This study evaluated the preoperative and postoperative brain natriuretic peptide levels in infants and children undergoing ventricular septal defect repair.

Methods: The study enrolled 18 infants and children (ages 2 months to 15.6 years) scheduled for surgical repair of their ventricular septal defects. Brain natriuretic peptide levels were drawn preoperatively and then postoperatively at 1, 24, 48, and 72 hours. The amount of shunt (the ratio of pulmonary blood flow [Qp]/systemic blood flow [Qs]) through the ventricular septal defect was determined by saturation levels performed in the catheterization laboratory or intraoperatively.

Results: The preoperative brain natriuretic peptide levels (pg/mL) averaged 78 ± 57, and the postoperative levels were 168 ± 241 at 1 hour, 418 ± 330 at 24 hours, 405 ± 364 at 48 hours, and 391 ± 397 at 72 hours. These differences were significant for each postoperative time point compared with preoperative values. Preoperative brain natriuretic peptide and the Qp/Qs were significantly correlated (age-adjusted R 2 = 0.33, p < 0.001).

Conclusions: Brain natriuretic peptide levels have a close correlation with the physiologic volume load caused by ventricular septal defects. The preoperative brain natriuretic peptide levels were also found to be predictive for the postoperative time course of brain natriuretic peptide level changes. These results suggest that brain natriuretic peptide levels may be a useful clinical marker in infants and children with ventricular septal defects.


    Introduction
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Brain natriuretic peptide (BNP) is a relatively recently discovered circulating mediator that is one of many natriuretic peptides produced by the heart and blood vessels in response to left ventricular volume expansion and pressure overload. As a group, these natriuretic hormones are vital in regulating extracellular fluid volume and blood pressure. Natriuretic hormones induce natriuresis, diuresis, and vasodilation, and they act specifically to counter the effects of the renin-angiotensin-aldosterone system [1, 2].

BNP levels have been shown to correlate with the incidence and severity of congestive heart failure in adult patients [3, 4]. This information has led to significant changes in the management of patients admitted to the hospital with congestive heart failure. Specifically, BNP levels provide a quantitative and prognostic measure of the severity of the patients’ heart failure [5, 6]. In addition, intravenous infusions of synthetically produced BNP (Nesiritide, Scios Inc, Mountain View, CA) have positively influenced the course of treatment for these patients [7]. BNP levels have also been shown to rise after cardiopulmonary bypass in adult patients, and there is some anecdotal experience suggesting that BNP infusions may facilitate diuresis and natriuresis in this setting as well [8].

In contrast, far less is known about BNP levels in infants and children born with congenital heart disease. The purpose of the present study was to evaluate BNP levels in infants and children having operations to repair ventricular septal defects (VSDs). We specifically sought to determine the relationship between preoperative BNP levels and the amount of left-to-right shunt through the VSD. In addition, we designed the study to evaluate the changes in BNP levels postoperatively. It was our hypothesis that BNP levels would correlate with the amount of left-to-right shunt attributable to the VSD.


    Material and Methods
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
The study cohort consisted of 10 boys and 8 girls, aged 2 months to 15.6 years, scheduled for surgical repair of their VSDs. The Institutional Review Board of Sutter Medical Center Sacramento approved the study, and written informed consent was obtained from the parents or guardians.

BNP levels were determined preoperatively and then postoperatively at 1, 24, 48, and 72 hours. The preoperative sample was drawn at the time of the preoperative blood testing and cross-match. The postoperative samples were drawn through the existing arterial or venous lines placed at the time of the procedure; thus, no patient required a separate venipuncture solely for the purpose of this study. Each BNP blood sample (2.5 mL) was placed into a purple-top tube that was immediately placed on ice. The samples were centrifuged and the plasma portion was separated in the Sutter Memorial chemistry laboratory.

Quantitative analysis was performed using the Abbott AxSym (Abbot Diagnostics, Abbott Park, IL) immunoassay system (Fig 1). This assay measured N-terminal prohormone BNP (NT-proBNP) with a microparticle enzyme immunoassay (MEIA). The precursor to both NT-proBNP (76 amino acids) and BNP (32 amino acids) is proBNP (108 amino acids). When proBNP is cleaved at the cellular membrane, the result is a 1:1 relationship between NT-proBNP and BNP. However, NT-proBNP has a longer half-life than the active hormone and is more stable in vitro. As a result, NT-proBNP assays are better standardized across platforms, with an interassay variation of less than 10% [9, 10].


Figure 1
View larger version (19K):
[in this window]
[in a new window]

 
Fig 1. The metabolic pathway of precursor prohormone brain natriuretic peptide (preproBNP), BNP, and N-terminal prohormone BNP (NT-proBNP) within the myocyte and after secretion into the extracellular space.

 
The amount of shunt (the ratio of pulmonary blood flow [Qp]/systemic blood flow [Qs]) through the VSD was determined using saturation values from the superior vena cava, inferior vena cava, and pulmonary artery. These blood samples were obtained in the catheterization lab in 5 patients and intraoperatively in 13.

Statistical analysis was performed using analysis of variance to compare preoperative BNP values between patients who were younger and older than age 1. The Wilcoxon test was performed to assess differences between the preoperative and postoperative BNP levels. Correlation coefficients and linear regression analysis were used to assess the association between preoperative BNP and Qp/Qs after adjustment for age (<1 year, 1+ years).


    Results
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Eighteen patients underwent VSD repair without surgical mortality. The average cross-clamp time was 42 ± 6 minutes, and the average bypass time was 80 ± 12 minutes. All 18 patients were extubated on the day of the procedure, and none required temporary or permanent pacing therapy. The average length of stay was 5 ± 2 days. No patient has had subsequent complications related to the congenital heart disease or repair, with an average follow-up of 15 ± 3 months.

Histograms showed that Qp/Qs and preoperative BNP were normally distributed. The mean Qp:Qs was 3.0 ± 1.84 (range, 1.4 to 5.6). Mean preoperative BNP was 78 ± 57 pg/mL (range, 15 to 175 pg/mL). The mean peroperative levels of BNP were 102 ± 47 pg/mL in patients younger than 1 year old and 57 ± 58 pg/mL in patients who were older than 1 year. These values were not statistically significantly different (p > 0.05). Mean Qp/Qs was 3.80 ± 1.05 for patients younger than age 1 and 2.19 ± 0.65 for patients older than age 1 (p < 0.01).

Postoperatively, BNP levels increased in all patients compared with the preoperative values and remained elevated throughout the study period. BNP levels at all four postoperative periods varied widely and were positively skewed (Table 1). The increase in BNP level was approximately threefold higher by 1 hour postoperatively compared with the preoperative level and was approximately fivefold higher at 24, 48, and 72 hours postoperatively. However, the increase in postoperative BNP levels was far greater in those patients whose preoperative levels were in the higher range. Figure 2 demonstrates the preoperative and postoperative BNP levels for these two groups by using a preoperative BNP level of greater or lesser than 75 pg/mL.


View this table:
[in this window]
[in a new window]

 
Table 1 Preoperative and Postoperative Brain Natriuretic Peptide Levels
 

Figure 2
View larger version (18K):
[in this window]
[in a new window]

 
Fig 2. Preoperative and postoperative brain natriuretic peptide (BNP) levels stratified by preoperative BNP level. (A) Change in BNP values of patients up to 3 days postoperatively are stratified by patients with preoperative BNP of less than 75 pg/mL and (B) more than 75 pg/mL.

 
The association between preoperative BNP levels and Qp/Qs is shown in Figure 3. The correlation between BNP Qp/Qs was 0.85 (unadjusted R 2 = 0.72; p < 0.001). After adjustment for age, BNP accounted for 33% of the variance of Qp/Qs. The equation


Formula

shows that in patients younger than age 1, the estimated Qp/Qs would be 2.59 with a preoperative BNP of 17 pg/mL, 3.28 with a BNP of 67 pg/mL, and 3.99 with a BNP of 117 pg/mL. These same values for patients older than age 1 are computed to be 1.77, 2.47, and 3.17, respectively.


Figure 3
View larger version (17K):
[in this window]
[in a new window]

 
Fig 3. Association of preoperative brain natriuretic peptide (BNP) (pg/mL) with preoperative pulmonary blood flow/systemic blood flow (Qp/Qs). Age adjusted R2 = 0.33.

 

    Comment
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
The results of the present study demonstrate a close correlation between preoperative levels of BNP and the amount of left-to-right shunt (Qp/Qs) through the ventricular septal defect. In addition, all patients demonstrated significant elevations in postoperative BNP. This was most prominent in those patients that had higher BNP and higher Qp/Qs values preoperatively. These results suggest that BNP levels do seem to have physiologic correlation with the clinical situation.

The introduction of plasma BNP to quantitatively assess the degree of heart failure has led to revolutionary changes in the management of adults with this disease [11]. The BNP levels identify early on those patients who are most at risk for poor outcome and allow for changes in their clinical management so that they are no longer at such high risk [12]. Infusions of BNP (nesiritide) for patients with New York Heart Association functional class IV heart failure result in prompt relief of dyspnea, a lowering of the pulmonary capillary wedge pressure, and excretion of sodium and water without adversely affecting renal function [2, 6, 7]. During the past 5 years, there have been more than 500 literature citations regarding BNP or nesiritide in adult patients with congestive heart failure.

In contrast to the adult literature, a very limited number of reports have been published about BNP in children. Costello and colleagues [13] evaluated 25 patients undergoing a variety of different congenital heart operations. Their results indicate that BNP levels were elevated postoperatively and positively associated with the duration of cardiopulmonary bypass. Shih and colleagues [14] studied 51 patients undergoing repair of congenital heart defects and also found that the postoperative BNP were elevated, with the 12-hour postoperative BNP level associated with the duration of mechanical ventilation and presence of a low cardiac output state. Several other articles [15] have documented alterations in plasma BNP levels in children with univentricular hearts and tetralogy of Fallot with pulmonary valve insufficiency and right ventricular dilatation [16].

In the present study, we chose to evaluate patients undergoing VSD repair for a number of reasons. First, VSDs are associated with variable degrees of left-to-right shunt and thus would be amenable to evaluating the relationship between BNP and Qp/Qs.

Second, the surgery for VSD repair is relatively uniform procedure and thus would minimize differences based on the surgical procedure itself. Additional factors that may facilitate achieving some uniformity are that all of the cardiac operations were performed by a single surgeon, and the postoperative management strategy was maintained in a consistent fashion from patient to patient. Thus, many important variables have been obviated, with Qp/Qs remaining the one important uncontrolled variable.

Third, because VSDs are the most common congenital heart defect requiring surgical intervention, enrollment of patients could proceed at a reasonable pace.

The results of the present study are consistent with previously published reports indicating a correlation exists between BNP and Qp/Qs [17, 18]. The strength of the correlation in our study suggests that plasma BNP levels could be used as a substitute for cardiac catheterization for the purpose of quantitative analysis. Specifically, a BNP level could be obtained and the corresponding Qp/Qs calculated from the equation described in Figure 3. The decision whether to recommend surgical intervention could then be based on this quantitative assessment (eg, Qp/Qs > 1.5 would benefit from surgery).

Our study also demonstrated that the plasma BNP levels were significantly elevated in the postoperative period, consistent with the findings of the two studies cited above. However, our study differed from previous studies in that it focused on a single congenital heart defect in patients who were having the same surgical procedure. In this cohort, the degree of postoperative elevation in BNP correlated with the relative increase in preoperative BNP and Qp/Qs. This indicates that the degree of heart failure preoperatively predicts the degree of BNP elevation both preoperatively and postoperatively.

Our results show that BNP levels increase postoperatively. Intuitively, one might anticipate that removing a volume load with the resultant reduction of ventricular size would be associated with a decrease in BNP. The data, however, indicate that the direction of change is opposite to that premise. Possible explanations for this observation include transient ventricular "stunning," diastolic dysfunction induced by perioperative geometric changes in the ventricle, or the effect of circulating mediators. However, the exact pathophysiology cannot be answered by this study.

A second question raised by this study is the length of time that the increase in BNP persists. The fact that the BNP levels are still markedly elevated on the third postoperative day seems surprising considering that many of the patients with lower Qp/Qs ratios were poised to go home on the fourth day. This persistent increase in BNP seems incongruous with the clinical situation. It would be intriguing to know how long the BNP levels remain elevated and whether this is dependent on the preoperative ratio of BNP to Qp/Qs values. Our study, however, was designed to avoid a separate venipuncture solely for the purpose of the study. The vascular access lines in many patients were removed on the third day in preparation for discharge, thus eliminating the possibility of drawing subsequent samples. For these reasons, we are not able to answer the question of how long the BNP levels remain elevated postoperatively.

In summary, the present study has demonstrated a close correlation between preoperative BNP and Qp/Qs, and we have shown that BNP levels are elevated postoperatively and are stratified according to their preoperative BNP levels. These results suggest that BNP levels may provide important clinical data before and after VSD repair. It is likely that BNP will have important diagnostic and therapeutic value in the future in children with congenital heart disease.


    References
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 

  1. Kelly R, Struthers AD. Are natriuretic peptides clinically useful as markers of heart failure? Ann Clin Biochem 2001;38:575-583.[Medline]
  2. Lainchbury JG, Espiner EA, Nicholls MG, Richards AM. Cardiac hormones: diagnostic and therapeutic potential N Z Med J 1997;110:219-221.[Medline]
  3. Wijbenga JA, Balk AH, Boomsma F, et al. Cardiac peptides differ in their response to exerciseImplications for patients with heart failure in clinical practice. Eur Heart J 1999;20:1424-1428.[Abstract/Free Full Text]
  4. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 2000;355:1126-1130.[Medline]
  5. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study Circulation 2002;106:416-422.[Abstract/Free Full Text]
  6. Colucci WS, Elkayam U, Horton DP, et al. Nesiritide Study Group Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure N Engl J Med 2000;343:246-253.[Abstract/Free Full Text]
  7. Mizuno O, Onishi K, Dohi K, et al. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure Am J Cardiol 2001;88:863-866.[Medline]
  8. Marshall J, Berkenbosch JW, Russo P, Tobias JD. Preliminary experience with nesiritide in the pediatric population J Intensive Care Med 2004;19:164-170.[Abstract/Free Full Text]
  9. Downie PF, Talwar S, Squire IB, et al. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction Clin Sci (Lond) 1999;97:255-258.[Medline]
  10. Karl J, Borgya A, Gallusser A, et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit Scand J Clin Lab Invest Suppl 1999;230:177-181.[Medline]
  11. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction Circulation 1998;97:1921-1929.[Abstract/Free Full Text]
  12. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 2002;347:161-167.[Abstract/Free Full Text]
  13. Costello JM, Backer CL, Checchia PA, et al. Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children J Thorac Cardiovasc Surg 2005;130:822-829.[Abstract/Free Full Text]
  14. Shih CY, Sapru A, Oishi P, et al. Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker J Thorac Cardiovasc Surg 2006;131:632-638.[Abstract/Free Full Text]
  15. Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM. Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects J Thorac Cardiovasc Surg 2005;129:1104-1110.[Abstract/Free Full Text]
  16. Dodge-Khatami A, Buchel EV, Knirsch W, et al. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation Ann Thorac Surg 2006;82:983-988.[Abstract/Free Full Text]
  17. Mir TS, Marohn S, Laer S, et al. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure Pediatrics 2002;110:e76.[Abstract/Free Full Text]
  18. Ootaki Y, Yamaguchi M, Yoshimura N, et al. Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease J Thorac Cardiovasc Surg 2003;126:1411-1416.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
N. Yoshimura, R. Henaine, Y. Ootaki, H. Matsuhisa, and T. Misaki
Why Does the Preoperative BNP Level Predict the Degree of Postoperative BNP Elevation?
Ann. Thorac. Surg., August 1, 2008; 86(2): 694 - 694.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. M.E. Koch
Plasma Levels of Brain Natriuretic Peptide in Children With Left-To-Right Shunt Before and After Cardiac Surgery
Ann. Thorac. Surg., August 1, 2008; 86(2): 693 - 694.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard D. Mainwaring
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mainwaring, R. D.
Right arrow Articles by Fallah, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mainwaring, R. D.
Right arrow Articles by Fallah, H.
Related Collections
Right arrow Congenital - acyanotic


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS